Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment

被引：128
作者：
Fleming, CA [1 ]
Craven, DE [1 ]
Thornton, D [1 ]
Tumilty, S [1 ]
Nunes, D [1 ]
机构：
[1] Boston Univ, Boston Med Ctr, Sch Med, Boston, MA 02118 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2003年 / 36卷 / 01期
关键词：
D O I：
10.1086/344907
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
One hundred eighty human immunodeficiency virus (HIV)- and hepatitis C virus (HCV)-coinfected patients were prospectively evaluated for suitability for interferon and ribavirin therapy. Of the 149 patients with chronic HCV infection who completed the evaluation, 44 (30%) were eligible for treatment and 105 (70%) were ineligible, with the main barriers being missed clinic visits, active psychiatric illness, active drug or alcohol use, decompensated liver disease, or medical illness.
引用
收藏
页码：97 / 100
页数：4
相关论文
共 10 条
  • [1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [2] [Anonymous], 1998, MMWR Recomm Rep, V47, P1
  • [3] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
    Bica, I
    McGovern, B
    Dhar, R
    Stone, D
    McGowan, K
    Scheib, R
    Snydman, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 492 - 497
  • [4] HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C
    Di Martino, V
    Thevenot, T
    Boyer, N
    Cazals-Hatem, D
    Degott, C
    Valla, D
    Marcellin, P
    [J]. AIDS, 2002, 16 (03) : 441 - 445
  • [5] The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study
    Di Martino, V
    Rufat, P
    Boyer, N
    Renard, P
    Degos, F
    Martinot-Peignoux, M
    Matheron, S
    Le Moing, V
    Vachon, F
    Degott, C
    Valla, D
    Marcellin, P
    [J]. HEPATOLOGY, 2001, 34 (06) : 1193 - 1199
  • [6] Surprisingly small effect of antiviral treatment in patients with hepatitis C
    Falck-Ytter, Y
    Kale, H
    Mullen, KD
    Sarbah, SA
    Sorescu, L
    McCullough, AJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (04) : 288 - 292
  • [7] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    [J]. LANCET, 2001, 358 (9286) : 958 - 965
  • [8] MIR J, 1998, P 36 GEN M INF DIS S
  • [9] Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders
    Sauleda, S
    Juárez, A
    Esteban, JI
    Altisent, C
    Ruiz, I
    Puig, L
    Esteban, R
    Guardia, J
    [J]. HEPATOLOGY, 2001, 34 (05) : 1035 - 1040
  • [10] Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group
    Sherman, KE
    Rouster, SD
    Chung, RT
    Rajicic, N
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) : 831 - 837
1